Follow
Bor-Sheng Ko
Bor-Sheng Ko
National Taiwan University Hospital
Verified email at ntu.edu.tw
Title
Cited by
Cited by
Year
Isolation of multipotent cells from human term placenta
BL Yen, HI Huang, CC Chien, HY Jui, BS Ko, M Yao, CT Shun, M Yen, ...
Stem cells 23 (1), 3-9, 2005
6062005
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
JL Tang, HA Hou, CY Chen, CY Liu, WC Chou, MH Tseng, CF Huang, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5352-5361, 2009
3612009
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking
DM Huang, Y Hung, BS Ko, SC Hsu, WH Chen, CL Chien, CP Tsai, ...
The FASEB journal 19 (14), 2014-2016, 2005
3452005
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
WC Chou, SC Chou, CY Liu, CY Chen, HA Hou, YY Kuo, MC Lee, BS Ko, ...
Blood, The Journal of the American Society of Hematology 118 (14), 3803-3810, 2011
3322011
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles
DM Huang, JK Hsiao, YC Chen, LY Chien, M Yao, YK Chen, BS Ko, ...
Biomaterials 30 (22), 3645-3651, 2009
3202009
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
HA Hou, YY Kuo, CY Liu, WC Chou, MC Lee, CY Chen, LI Lin, MH Tseng, ...
Blood, The Journal of the American Society of Hematology 119 (2), 559-568, 2012
2652012
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
WC Chou, HH Huang, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, BS Ko, ...
Blood, The Journal of the American Society of Hematology 116 (20), 4086-4094, 2010
2302010
The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells
YC Chen, JK Hsiao, HM Liu, IY Lai, M Yao, SC Hsu, BS Ko, YC Chen, ...
Toxicology and applied pharmacology 245 (2), 272-279, 2010
1812010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system
HA Hou, TC Huang, LI Lin, CY Liu, CY Chen, WC Chou, JL Tang, ...
Blood, The Journal of the American Society of Hematology 115 (25), 5222-5231, 2010
1752010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
WC Chou, WC Lei, BS Ko, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, ...
Leukemia 25 (2), 246-253, 2011
1722011
RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is …
CY Chen, LI Lin, JL Tang, BS Ko, W Tsay, WC Chou, M Yao, SJ Wu, ...
British journal of haematology 139 (3), 405-414, 2007
1652007
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
SJ Wu, YY Kuo, HA Hou, LY Li, MH Tseng, CF Huang, FY Lee, MC Liu, ...
Blood, The Journal of the American Society of Hematology 120 (15), 3106-3111, 2012
1432012
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution
HA Hou, WC Chou, YY Kuo, CY Liu, LI Lin, MH Tseng, YC Chiang, ...
Blood cancer journal 5 (7), e331-e331, 2015
1292015
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
CH Tsai, HA Hou, JL Tang, CY Liu, CC Lin, WC Chou, MH Tseng, ...
Leukemia 30 (7), 1485-1492, 2016
1022016
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease …
CC Lin, HA Hou, WC Chou, YY Kuo, CY Liu, CY Chen, YJ Lai, MH Tseng, ...
American journal of hematology 89 (2), 137-144, 2014
932014
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
HA Hou, CC Lin, WC Chou, CY Liu, CY Chen, JL Tang, YJ Lai, MH Tseng, ...
Leukemia 28 (1), 50-58, 2014
922014
Cyclooxygenase-2-Derived Prostaglandin E2 Protects Mouse Embryonic Stem Cells from Apoptosis
JY Liou, DP Ellent, S Lee, J Goldsby, BS Ko, N Matijevic, JC Huang, ...
Stem Cells 25 (5), 1096-1103, 2007
922007
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
TC Chen, HA Hou, WC Chou, JL Tang, YY Kuo, CY Chen, MH Tseng, ...
Blood cancer journal 4 (1), e177-e177, 2014
912014
Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia–the occurrence of retinoic acid syndrome is a risk factor
BS Ko, JL Tang, YC Chen, M Yao, CH Wang, MC Shen, HF Tien
Leukemia 13 (9), 1406-1408, 1999
911999
Acute myeloid leukemia bearing t (7; 11)(p15; p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients
WC Chou, CY Chen, HA Hou, LI Lin, JL Tang, M Yao, W Tsay, BS Ko, ...
Leukemia 23 (7), 1303-1310, 2009
772009
The system can't perform the operation now. Try again later.
Articles 1–20